Total Payments
$9,823
2024 Payments
$874.68
Companies
28
Transactions
414
Medicare Patients
7,597
Medicare Billing
$452,733
Payment Breakdown by Category
Food & Beverage$9,022 (91.8%)
Travel$774.53 (7.9%)
Education$26.50 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,022 | 405 | 91.8% |
| Travel and Lodging | $774.53 | 5 | 7.9% |
| Education | $26.50 | 4 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $2,152 | 63 | $0 (2024) |
| Amgen Inc. | $1,319 | 65 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $929.08 | 51 | $0 (2023) |
| Abbott Laboratories | $741.84 | 6 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $719.15 | 49 | $0 (2020) |
| ShockWave Medical, Inc | $640.82 | 4 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $589.94 | 33 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $576.85 | 32 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $550.46 | 26 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $218.27 | 14 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $874.68 | 31 | Amgen Inc. ($232.84) |
| 2023 | $1,948 | 55 | Boston Scientific Corporation ($1,173) |
| 2022 | $1,250 | 36 | Shockwave Medical, Inc ($594.78) |
| 2021 | $832.61 | 41 | BOSTON SCIENTIFIC CORPORATION ($181.82) |
| 2020 | $558.37 | 27 | Janssen Pharmaceuticals, Inc ($162.58) |
| 2019 | $1,132 | 56 | Boehringer Ingelheim Pharmaceuticals, Inc. ($264.69) |
| 2018 | $1,597 | 69 | Abbott Laboratories ($435.55) |
| 2017 | $1,631 | 99 | Janssen Pharmaceuticals, Inc ($362.72) |
All Payment Transactions
414 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Abbott Laboratories | AMPLATZER AMULET (Device) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Structural Heart | ||||||
| 12/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/26/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: Cardiology | ||||||
| 10/29/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Cardiology | ||||||
| 10/18/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 10/03/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: Cardiology | ||||||
| 10/01/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 09/23/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/19/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Not Applicable | ||||||
| 09/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $34.63 | General |
| Category: Diabetes | ||||||
| 09/03/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: Cardiology | ||||||
| 08/20/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: Not Applicable | ||||||
| 08/07/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 08/06/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $25.23 | General |
| Category: Cardiology | ||||||
| 07/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/09/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $114.99 | General |
| Category: General - Balloon Catheters_ICG | ||||||
| 07/09/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: Cardiology | ||||||
| 07/09/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $3.07 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/30/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: Genetic Disease | ||||||
| 05/23/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $30.03 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/21/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: Cardiology | ||||||
| 04/23/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $26.52 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/16/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: Cardiology | ||||||
| 04/11/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: Genetic Disease | ||||||
| 03/26/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 2,007 | 2,364 | $699,804 | $131,001 |
| 2022 | 22 | 2,056 | 2,359 | $606,192 | $118,125 |
| 2021 | 22 | 1,751 | 2,000 | $561,859 | $109,592 |
| 2020 | 20 | 1,783 | 1,964 | $498,604 | $94,015 |
Total Patients
7,597
Total Services
8,687
Medicare Billing
$452,733
Procedure Codes
97
All Medicare Procedures & Services
97 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 357 | 523 | $166,314 | $43,766 | 26.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 137 | 139 | $117,316 | $19,021 | 16.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 158 | 158 | $77,736 | $17,818 | 22.9% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 50 | 52 | $52,520 | $10,172 | 19.4% |
| 93350 | Ultrasound of heart during rest, exercise and/or drug-induced stress with report | Office | 2023 | 45 | 45 | $34,380 | $6,088 | 17.7% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 11 | 12 | $25,032 | $4,767 | 19.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 70 | 70 | $20,230 | $3,628 | 17.9% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 509 | 576 | $48,900 | $3,414 | 7.0% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 17 | 33 | $14,124 | $2,883 | 20.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 20 | 20 | $16,860 | $2,510 | 14.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 218 | 228 | $16,188 | $2,322 | 14.3% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 13 | 52 | $8,731 | $2,232 | 25.6% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 25 | 28 | $24,500 | $2,198 | 9.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 21 | 37 | $11,211 | $2,169 | 19.3% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 31 | 31 | $10,447 | $1,453 | 13.9% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 17 | 18 | $9,291 | $1,388 | 14.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 14 | 14 | $8,022 | $1,336 | 16.7% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 11 | 11 | $9,889 | $1,082 | 10.9% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 62 | 66 | $9,527 | $614.00 | 6.4% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Office | 2023 | 29 | 29 | $2,929 | $395.92 | 13.5% |
| 93225 | Electrocardiogram (ecg) 2-day continuous | Office | 2023 | 30 | 30 | $3,030 | $394.49 | 13.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 67 | 67 | $2,211 | $339.30 | 15.3% |
| 85610 | Blood test, clotting time | Office | 2023 | 36 | 64 | $4,352 | $268.80 | 6.2% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 18 | 19 | $2,871 | $247.07 | 8.6% |
| 93272 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | Office | 2023 | 13 | 13 | $1,248 | $241.15 | 19.3% |
About Dr. Brian Long, MD
Dr. Brian Long, MD is a Interventional Cardiology healthcare provider based in Nashville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1245313741.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Long, MD has received a total of $9,823 in payments from pharmaceutical and medical device companies, with $874.68 received in 2024. These payments were reported across 414 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($9,022).
As a Medicare-enrolled provider, Long has provided services to 7,597 Medicare beneficiaries, totaling 8,687 services with total Medicare billing of $452,733. Data is available for 4 years (2020–2023), covering 97 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Location Nashville, TN
- Active Since 10/20/2006
- Last Updated 12/27/2025
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1245313741
Products in Payments
- Repatha (Biological) $1,054
- XARELTO (Drug) $719.15
- PRADAXA (Drug) $609.32
- SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER (Device) $594.78
- LifeVest (Device) $589.94
- ENTRESTO (Drug) $357.66
- Asahi Fielder coronary guide wire (Device) $336.18
- JARDIANCE (Drug) $319.76
- WATCHMAN Access System (Device) $312.18
- PRALUENT (Drug) $292.20
- MULTAQ (Drug) $284.65
- Corlanor (Drug) $254.36
- WATCHMAN (Device) $219.09
- PRALUENT ALIROCUMAB INJECTION (Biological) $218.27
- LEQVIO (Drug) $192.80
- Arcalyst (Drug) $170.08
- ELIQUIS (Drug) $168.57
- Xience Xpedition coronary stent system (Device) $156.29
- AMPLATZER AMULET (Device) $150.00
- BRILINTA (Drug) $144.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Interventional Cardiology Doctors in Nashville
Dr. Nadia Sutton, Md, MD
Interventional Cardiology — Payments: $294,486
Interventional Cardiology $294,486
Dr. Osama Ibrahim, Md, MD
Interventional Cardiology — Payments: $92,884
Interventional Cardiology $92,884
Dr. Jay Patel, M.d, M.D
Interventional Cardiology — Payments: $47,544
Interventional Cardiology $47,544
Leah Raj, Md, MD
Interventional Cardiology — Payments: $47,514
Interventional Cardiology $47,514
Dr. Bimal Padaliya, M.d, M.D
Interventional Cardiology — Payments: $40,208
Interventional Cardiology $40,208
Dr. Ann Gage, M.d, M.D
Interventional Cardiology — Payments: $21,572
Interventional Cardiology $21,572